CAS 1402345-92-9

Fórmula: C27H18F5N5O4S

InChI: InChI=1S/C27H18F5N5O4S/c1-41-24-23(42(39,40)36-21-9-7-16(28)12-19(21)29)11-15(13-34-24)14-6-8-20-17(10-14)25(38)37(26(33)35-20)22-5-3-2-4-18(22)27(30,31)32/h2-13,36H,1H3,(H2,33,35)

Clave InChI: MSRFVAYVUUHQCN-UHFFFAOYSA-N

SMILES: COC1=C(C=C(C=N1)C2=CC3=C(C=C2)N=C(N(C3=O)C4=CC=CC=C4C(F)(F)F)N)S(=O)(=O)NC5=C(C=C(C=C5)F)F

GSK-F1

CAS: 1402345-92-9

GSK-F1

Fórmula: C₂₇H₁₈F₅N₅O₄S

Pureza: 97%

Peso molecular: 603.52

Ref: 54-BUP07202

GSK-F1

CAS: 1402345-92-9

Fórmula: C₂₇H₁₈F₅N₅O₄S

Pureza: 98%

Peso molecular: 603.5199

Ref: IN-DA00A18O

GSK-F1

CAS: 1402345-92-9

Ref: 7W-GW7601

GSK-F1

CAS: 1402345-92-9

5-(2-Amino-4-oxo-3-(2-(trifluoromethyl)phenyl)-3,4-dihydroquinazolin-6-yl)-N-(2,4-difluorophenyl)-2-methoxypyridine-3-sulfonamide

Fórmula: C₂₇H₁₈F₅N₅O₄S

Pureza: 98+%

Peso molecular: 603.52

Ref: IN-DG637007

GSK-F1

CAS: 1402345-92-9

GSK-F1 (PI4KA inhibitor-F1) is a novel potent PI4KA inhibitor.

Fórmula: C₂₇H₁₈F₅N₅O₄S

Pureza: 97.03%

Forma y color: Solid

Peso molecular: 603.52

Ref: TM-T19840